Pathogenesis: Immunogenetic factors

Best Practice and Research: Clinical Rheumatology

Volumn 15, Issue 2, 2001, Pages 239-258

  Huang, DeRen ^a   Zhou, Yihua ^a   Hoffman, Gary S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cytokine; Cytotoxic T lymphocyte associated antigen 4; Genetics; Giant cell arteritis; MHC; Polymorphisms; Systemic vasculitis; Takayasu's arteritis; Wegener's granulomatosis

Indexed keywords

CD28 ANTIGEN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FC RECEPTOR; IMMUNOGLOBULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

AORTA ARCH SYNDROME; DISEASE COURSE; ENVIRONMENTAL FACTOR; GENE FUNCTION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC POLYMORPHISM; GIANT CELL ARTERITIS; HEREDITY; HUMAN; IMMUNE RESPONSE; IMMUNOGENETICS; IMMUNOREGULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SYSTEMIC VASCULITIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; WEGENER GRANULOMATOSIS;

EID: 0034993652     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1053/berh.2001.0142     Document Type: Article

References (133)

1. Chronic parvovirus B19 infection and systemic necrotising vasculitis: Opportunistic infection or aetiological agent?
2. Polyarteritis nodosa and parvovirus B19 infection
3. Assoclation of Wegener's granulomatosis with parvovirus B19 infection: Comment on the concise communication by Nikkari et al
4. A role for hepatitis C virus infection in type II cryoglobulinemia
5. Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia
6. Necrotizing vasculitis and HIV replication in peripheral nerves
7. The spectrum of vasculitis in human immunodeficiency virus-infected patients. A clinicopathologic evaluation
8. Temporal artery biopsy: A diagnostic tool for systemic necrotizing vasculitis. French Vasculitis Study Group
9. Large-vessel arteritis associated with chronic active Epstein-Barr virus infection
10. GB virus C in systemic medium- and small-vessel necrotizing vasculitides
11. Familial vasculitis: Report of 2 families
12. Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: A pilot study in II patients with renal involvement
13. Environmental trigger for anti-neutrophil cytoplasmic antibodies?
14. Giant cell arteritis with ocular complications discovered simultaneously in two sisters
15. Polymyalgia arteritica
16. Familial aggregation of polymyalgia rheumatica and giant cell arteritis
17. Polymyalgia arteritica. A report on five cases within a family
18. Familial association of giant cell arteritis. A case report and brief review
19. Giant cell arteritis in two brothers
20. Familial giant cell arteritis: Report of an HLA-typed sibling pair and a review of the literature
21. Familial Horton's disease. Possible relationship with the A28, CW3, B15, DR4 HLA haplotype
22. Male siblings with Takayasu's arteritis suggest genetic etiology
23. Takayasu's disease in twin sisters
24. Takayasu's disease in two brothers. Analysis of HLA types
25. Polyarteritis nodosa in identical twins
26. Familial polyarteritis nodosa
27. Polyarteritis nodosa in two siblings
28. On familial polyarteritis nodosa
29. Familial polyarteritis nodosa: A serologic and immunogenetic analysis
30. Wegener's granulomatosis in a family. A short report
31. Wegener's granulomatosis in two siblings: A family study
32. Wegener's granulomatosis in two sisters
33. Wegener's granulomatosis occurring in siblings
34. Time-associated Wegener's granulomatosis in two members of a family
35. A case of Wegener's granulomatosis in married couples
36. Acute renal failure due to microscopic polyarteritis with the same histological and clinical patterns in a father and his son
37. Brother and sister with myeloperoxidase associated autoimmune disease
38. Goodpasture's syndrome in twins
39. Goodpasture's syndrome in identical twins
40. Goodpasture's syndrome. Cessation of pulmonary hemorrhage after bilateral nephrectomy
41. Genetic susceptibility to the development of autoimmune disease
42. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy
43. Case report: Hashimoto's thyroiditis associated with Wegener's granulomatosis
44. Case of propylthiouracil-induced vasculitis associated with anti-neutrophil cytoplasmic antibody (ANCA); Review of literature
45. Wegener's granulomatosis and relapsing polychondritis: A case report
46. Wegener's granulomatosis (WG) and insulin dependent diabetes mellitus (IDDM)
47. A genome-wide search for human type I diabetes susceptibility genes
48. Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome IIq
49. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22
50. HLA-A antigens of patients with Wegener's granulomatosis
51. HLA antigen frequencies and Wegener's granulomatosis
52. Distribution of MHC class II alleles in primary systemic vasculitis
53. Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms
54. Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association
55. Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy
56. Relation between HLA DRBI alleles and corticosteroid resistance in giant cell arteritis
57. Distribution of HLA-DRBI alleles of patients with polymyalgia rheumatica and giant cell arteritis in a Mediterranean population
58. Molecular analysis of HLA-DR polymorphism in polymyalgia rheumatica. Swiss Group for Research on HLA in Polymyalgia Rheumatica
59. HLA-DRBI alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis
60. Mapping of the HLA-linked genes controlling the susceptibility to Takayasu's arteritis
61. Immunogenetic analysis of Takayasu arteritis in Indian patients
62. Association of clinical manifestations with HLA-B alleles in Takayasu arteritis
63. The association between the HLA antigens and Takayasu's arteritis in Thai patients
64. HLA typing in patients with Wegener granulomatosis
65. Association of Wegener's granulomatosis with HLA antigens and other genetic markers
66. Necrotizing vasculitis in Greece: Clinical, immunological and immunogenetic aspects. A study of 66 patients
67. Decreased frequency of HLA-DR13DR6 in Wegener's granulomatosis
68. Association of a syndrome resembling Wegener's granulomatosis with low surface expression of HLA class-I molecules
69. Molecular basis of Fc receptor function
70. Allelic polymorphisms of human Fc gamma receptor IIA and Fc gamma receptor IIIB. Independent mechanisms for differences in human phagocyte function
71. On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2
72. Fcgamma receptor polymorphisms in Wegener's granulomatosis: Risk factors for disease relapse
73. Analysis of FcgammaRII gene polymorphisms in Wegener's granulomatosis
74. Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients
75. Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans
76. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis: A predominant role for the IgG3 subclass of ANCA
77. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): A Fc gamma RII-dependent process
78. Receptors for immunoglobulin G. Molecular diversity and implications for disease
79. Fc gamma receptor IIIb enhances Fc gamma receptor IIa function in an oxidant-dependent and allele-sensitive manner
80. Role of neutrophil Fc gamma RIIa (CD32) and Fc gamma RIIIb (CD16) polymorphic forms in phagocytosis of human IgGI- and IgG3-opsonized bacteria and erythrocytes
81. No association between neutrophil FcgammaRIIa allelic polymorphism and anti-neutrophil cytoplasmic antibody (ANCA)-positive systemic vasculitis
82. Genetic polymorphism of human interleukin-1 alpha
83. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism
84. A Taql polymorphism in the human interleukin-1 beta (IL-1 beta) genecorrelates with IL-1 beta secretion in vitro
85. Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta)
86. Anti-neutrophil cytoplasmic autoantibodies induced neutrophils to degranulate and produce oxygen radicals in vitro
87. Recombinant human tumor necrosis factor-alpha. Regulation of N-formylmethionylleucylphenylalanine receptor affinity and function on human neutrophils
88. + T cells exhibiting an unbalanced Th I-type T cell cytokine pattern: Reversal with IL-10
89. In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis
90. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: A multicenter study
91. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles
92. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation
93. Tumour necrosis factor gene polymorphisms as severity markers in rheumatoid arthritis
94. Impact of the - 308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: Relevance to disease
95. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans
96. The - 308 tumor necrosis factor-alpha promoter polymorphism effects transcription
97. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome
98. Tumour necrosis factor-alpha polymorphism and secretion in myasthenia gravis
99. Polymorphism of the human TNF-alpha promoter - Random variation or functional diversity?
100. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria
101. Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease
102. Polymorphism in tumor necrosis factor genes associated with mococutaneous leishmaniasis
103. Tumor necrosis factor a microsatellite polymorphism is associated with rheumatoid arthritis severity through an interaction with the HLA-DRBI shared epitope
104. Polymorphisms in CTLA-4 but not tumor necrosis factor-alpha or interleukin 1 beta genes are associated with Wegener's granulomatosis
105. Identification of novel polymorphisms in the human TNFRI gene: Distribution in acute leukemia patients and health individuals
106. Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus
107. Cytokine profiles in Wegener's granulomatosis: Predominance of type I (Th1) in the granulomatous inflammation
108. Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: A new model for virus-induced vascular disease
109. Interleukin-10: Biology, role in inflammation and autoimmunity
110. A polymorphic dinucleotide repeat in the human IL-10 promoter
111. Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus
112. Mapping of the human IL10 gene and further characterization of the 5′ flanking sequences
113. Markers in the promoter region of interleukin-10 (IL-10) gene in myasthenia gravis: Implications of diverse effects of IL-10 in the pathogenesis of the disease
114. Cytokine gene polymorphism and heart transplant rejection
115. + lymphocyte subsets in Wegener's granulomatosis
116. + T-cell subsets in Wegener's granulomatosis
117. T-cell expansions with conserved T-cell receptor beta chain motifs in the peripheral blood of HLA-DRBI*0401 positive patients with necrotizing vasculitis
118. T cell receptor (TCR) V gene usage in patients with systemic necrotizing vasculitis
119. The Yin and Yang of T cell costimulation
120. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation
121. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells
122. Enhancement of antitumor immunity by CTLA-4 blockade
123. Differential T cell costimulatory requirements in CD28-deficient mice
124. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4
125. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
126. Human Ig superfamily CTLA-4 gene: Chromosomal localization and identity of protein between murine and human CTLA-4 cytoplasmic domains
127. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population
128. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type I diabetes. Belgian Diabetes Registry
129. Genetic association of Ctla-4 to myasthenia gravis with thymoma
130. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation
131. Cutting edge: Clustered AU-rich elements are the targets of IL-10-mediated mRNA destabilization in mouse macrophages
132. Specific association of human telomerase activity with immortal cells and cancer